1. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Global Alliance to Improve Outcomes in Acne, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009. 60:Suppl 5. 1–50.
Article
2. Simpson N. Antibiotics in acne: time for a rethink. Br J Dermatol. 2001. 144:225–227.
Article
3. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000. 115:183–192.
Article
4. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol. 2001. 144:575–579.
Article
5. Pollock B, Turner D, Stringer MR, Bojar RA, Goulden V, Stables GI, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004. 151:616–622.
Article
6. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990. 136:891–897.
7. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992. 14:275–292.
8. Moseley H, Ibbotson S, Woods J, Brancaleon L, Lesar A, Goodman C, et al. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre. Lasers Surg Med. 2006. 38:403–416.
Article
9. Na JI, Kim SY, Kim JH, Youn SW, Huh CH, Park KC. Indole-3-acetic acid: a potential new photosensitizer for photodynamic therapy of acne vulgaris. Lasers Surg Med. 2011. 43:200–205.
Article
10. Goldsmith MH. Cellular signaling: new insights into the action of the plant growth hormone auxin. Proc Natl Acad Sci U S A. 1993. 90:11442–11445.
Article
11. Folkes LK, Wardman P. Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochem Pharmacol. 2001. 61:129–136.
Article
12. Kim DS, Jeon SE, Park KC. Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells. Cell Signal. 2004. 16:81–88.
Article
13. Kim DS, Kim SY, Jeong YM, Jeon SE, Kim MK, Kwon SB, et al. Light-activated indole-3-acetic acid induces apoptosis in g361 human melanoma cells. Biol Pharm Bull. 2006. 29:2404–2409.
Article
14. Sung KJ, Rho YS, Choi EH, Oh JJ, Lee JH, Kim S, et al. Korean acne grading system. Korean J Dermatol. 2004. 42:1241–1247.
15. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008. 159:997–1035.
Article
16. Wardman P. Indole-3-acetic acids and horseradish peroxidase: a new prodrug/enzyme combination for targeted cancer therapy. Curr Pharm Des. 2002. 8:1363–1374.
17. Greco O, Folkes LK, Wardman P, Tozer GM, Dachs GU. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther. 2000. 7:1414–1420.
Article
18. Park KC, Kim SY, Kim DS. Experimental photodynamic therapy for liver cancer cell-implanted nude mice by an indole-3-acetic acid and intense pulsed light combination. Biol Pharm Bull. 2009. 32:1609–1613.
Article
19. Kim SY, Kim MK, Kwon SB, Na JI, Park KC, Kim DS. Tumor apoptosis by indole-3-acetic acid/light in B16F10 melanoma-implanted nude mice. Arch Dermatol Res. 2009. 301:319–322.
Article